Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 576
Aptamer sequence: ACCTTCGGGGAGTATTGCGGAGGAAGGT
Target unique ID: 6083
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_517 One-site Apt Molecule Adenosine monophosphate 13.5 μM 300 mM NaC1, 5 mM MgC12, 20 mM Tris (pH 7.6) 34084332
Structure information of aptamer
Aptamer Sequence: ACCTTCGGGGAGTATTGCGGAGGAAGGT
The optimal secondary structure in dot-bracket notation: .((((((.((....)).)))))).....
The centroid secondary structure in dot-bracket notation: .((((((.(......).)))))).....
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_517 Description One-site Apt
Aptamer chemistry DNA Length 28 nt
GC content 57.1% Molecular weight 8,749.63 Da
Molarity of 1 μg/μl solution 114.29 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Aptasensor
Sequence ACCTTCGGGGAGTATTGCGGAGGAAGGT
Applications Specifific recognition of adenosine
Target information
Type Detail Type Detail
PubChem ID 6083 Molecular name Adenosine monophosphate
Molecular formula C10H14N5O7P Molecular weight 347.22
IUPAC name [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate InChIKey UDMBCSSLTHHNCD-KQYNXXCUSA-N
LogP -1.863 Topological polar surface area 186.07
Hydrogen bond acceptor 10 Hydrogen bond donor 5

Synonym(s):
adenosine 5'-monophosphate; 5'-adenylic acid; adenosine phosphate; Adenosine monophosphate; 61-19-8; adenylic acid; adenosine 5'-phosphate; 5'-AMP; adenylate; Phosphentaside; Adenovite; Phosphaden; Cardiomone; Lycedan; Phosaden; AMP; Vitamin B8; Adenosine-5'-monophosphate; My-B-Den; Myoston; Ergadenylic acid; Monophosphadenine; Muscle adenylic acid; Muskeladenylsaeure; 5'-adenosine monophosphate; AMP (nucleotide); Adenosine 5'-(dihydrogen phosphate); Adenosine 5'-phosphoric acid; Adenosini phosphas; Adenosine-5-monophosphoric acid; Adenosine-5'-monophosphoric acid; Fosfato de adenosina; Phosphate d'adenosine; Adenosine-5-phosphate; adenosine-monophosphate; PAdo; Adenylic acid (VAN); Muskeladenosin-phosphorsaeure; adenosine-5'P; adenosine-phosphate; AMP (VAN); Ado5'P; 5'-O-phosphonoadenosine; A5MP; Adenosini phosphas [INN-Latin]; Adenosine 5'-monophosphoric acid; Fosfato de adenosina [INN-Spanish]; Phosphate d'adenosine [INN-French]; Adenosine, mono(dihydrogen phosphate) (ester); HSDB 3281; NSC-20264; UNII-415SHH325A; BRN 0054612; CHEBI:16027; [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate; Adenosine phosphate [USAN:BAN:INN]; Adenosine 5' monophosphate; CHEMBL752; A 5MP; a-5mp; 415SHH325A; {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid; ((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate; C10H14N5O7P; NCGC00163319-01; NCGC00163319-03; Adenyl; DSSTox_CID_2560; DSSTox_RID_76630; DSSTox_GSID_22560; 122768-03-0; 136920-07-5; Adenosine 5-Monophosphate; 7gpb; 8gpb; CAS-61-19-8; Adenosine phosphate [USAN:INN:BAN]; Acetamide, 2,2,2,2-(1,2-ethanediyldinitrilo)tetrakis-, N,N,N,N,N,N,N,N-octa-C12-18-alkyl derivs.; adenosin-5'-monophosphat; Adenyl (TN); MFCD00005750; MFCD00149360; EINECS 200-500-0; NSC 20264; Adenosine 5 -monophosphate; Adenosine Monophosphate (Amp); Muscle adenylate; 5'adenylic acid; Adenosine 5'-monophosphate, free acid; Adenosine phosphate (USAN/INN); 1pyg; 2gsu; 5'-adenylate; My-beta-Den; Adenosine-5'-Monophosphate, Free acid; 1ua4; 1z6s; Adenosin-5-monophosphate; Adenosine 5'-phosphorate; Adenosine5'-monophosphate; Prestwick0_000356; Prestwick1_000356; Prestwick2_000356; Prestwick3_000356; bmse000005; bmse000873; bmse000992; Epitope ID:137353; Adenosine-5-monophosphorate; SCHEMBL5588; Adenosine-5'-monophosphorate; adenosine-5'-phosphoric acid; BSPBio_000451; 4-26-00-03615 (Beilstein Handbook Reference); SPBio_002372; BPBio1_000497; GTPL2455; [3h]adenosine 5'-monophosphate; DTXSID5022560; SCHEMBL18287224; BDBM18137; 7A8E6D15-9136-44C1-88C9-E1A224638E56; AMY30021; HY-A0181; ZINC3860156; Tox21_112046; s9366; AKOS015833068; AKOS015888563; Tox21_112046_1; CCG-267996; DB00131; Adenosine 5'-Monophosphate, free acid; Adenosine 5\\'-monophosphate monohydrate; NCGC00163319-02; [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl dihydrogen phosphate; 67583-85-1; AS-11783; AB0010740; Adenosine Monophosphate (5'-Adenylic Acid); DB-022416; A0158; CS-0017523; C00020; D02769; F20323; 005A750; Adenosine-3(+2')-monophosphoric acid monohydrate*; Q318369; J-700145; W-105182; Adenosine 5'-monophosphate-Agarose, lyophilized powder; Adenosine 5'-monophosphate-Agarose, saline suspension; 9H-Purin-6-amine, 9-(5-O-phosphono-.beta.-D-ribofuranosyl)-; 9H-purin-6-amine, 9-(5-O-phosphono-beta-D-ribofuranosyl)-; [(2R,3S,4R,5R)-5-adenin-9-yl-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl dihydrogen phosphate;hydrate; Adenosine 5'-monophosphate-Agarose, lyophilized powder, Contains lactose stabilizers that must be removed prior to use.

Activity data
Interaction ID 540
Target type Molecule
Target unique ID 60961
Activity 2.8 μM
Binding Conditions/Buffer

300 mM NaCl, 5 mM MgC12, 20 mM Tris (pH 7.6)

Assay

ITC traces and integrated heat for 20 mM one-site aptamer titrated

PubMed ID 34084332
Interaction ID 576
Target type Molecule
Target unique ID 6083
Activity 13.5 μM
Binding Conditions/Buffer

300 mM NaC1, 5 mM MgC12, 20 mM Tris (pH 7.6)

Assay

ITC traces and integrated heat for 20 mM one-site aptamer titrated

PubMed ID 34084332
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_515 DNA CCTGGGGGAGTATTGCGGAGGAAGG
85.71%
Apta_552 DNA CACCTGGGGGAGTATTGCGGAGGAAGGTTCCAGGTG 69.44%
Apta_829 DNA CCCTCCGGGGGGGTCATCGGGATACCTGGTAAGGATA 59.46%
Apta_302 DNA ATCCTGTGAGGAATGCTCATGCATAGCAAGGGCT 58.82%
Apta_126 DNA TCCTCATATAGAGTGCGGGGCGTGT 57.14%
Apta_483 DNA ATTGGGAGGGATTGGGTGGG 57.14%
Apta_1203 DNA CCCTGCGGGGCTACCCGATATGTGTCCGAGTGGTG 57.14%
Apta_578 DNA CACCAAGCGCAGGGAATTACATTGAAGTGTGGGATTGGCT 55.00%
Apta_1095 DNA CCCTGAGGGGTGATGTGAATCCTAACAGTAAGGAGGAAGG 55.00%
Apta_1208 DNA CCCTGCGGGGCTGCCCGATATGTGTCCAGGTGGTG 54.29%
Apta_150 DNA CCGTAGGTTCGGGGCGGAGTGGTCCGGAAGGTGGCGTGG 53.85%
Apta_21 DNA TGTGGGGGAGGACGGGCGGGGATGC 53.57%
Apta_28 DNA AGTGGGGGGGGTGGAGCCGGGTAGA 53.57%
Apta_389 DNA GCCTGTGGTGTTGGGGCGGGTGCG 53.57%
Apta_420 DNA AGGGACGGGCTAAGTAACTGTGGAGGGT 53.57%
Apta_671 DNA GCATCTGATCGGGTGTGGGTGGCGTAAAGG 53.33%
Apta_148 DNA CCGTAGGTTCGGGGTCGGAGTGGTCCGGAAGGTGGCGTGG 52.50%
Apta_149 DNA CCGTAGGTTCGGGGTCGGAGTGGTCCGGAAGATGGCGTGG 52.50%
Apta_183 DNA TAGCACTGTGCGGCGCGTATTGTTCTAATCTGATTACATT 52.50%
Apta_258 DNA CACTGCGGGGGTCTATACGTGAGGAAGAAGTGGGCAGGTC 52.50%